Chinese biotech company with 'zero' revenue surges 4,500% since stock market debut
For the most recent quarter that ended in June 30, TransThera posted zero revenue. The company's drugs are still in clinical testing with none commercialised yet. The company only has 121 employees.

What's Your Reaction?











